3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
61
Recurrence
10
Lymphoma
5
Waldenstrom Macroglobulinemia
4
Neoplasms, Plasma Cell
4
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sezary Syndrome
1
Salivary Gland Adenoma, Pleomorphic
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmacytoma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia
1
Kidney Failure, Chronic
1
Interventions
fludarabine phosphate
22
Mycophenolic Acid
17
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
13
Cyclophosphamide
12
Cyclosporine
11
Tacrolimus
10
Cyclosporins
9
Antilymphocyte Serum
9
Busulfan
8
fludarabine
7
Rituximab
7
Sirolimus
5
Methotrexate
5
Melphalan
4
Filgrastim
3
Cytarabine
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
pegfilgrastim
2
ibrutinib
2
Thiotepa
2
Oxaliplatin
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Darbepoetin alfa
2
Clofarabine
2
selinexor
1
sargramostim
1
ofatumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic
×
carfilzomib
×
Clear all
No trials found.